Stephen G Withers

USPTO Granted Patents = 20 (Patent Applications = 10)

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 3.4

ph-index = 8

Forward Citations = 234(Granted Patents)

Company Filing History:

19 out of 932

The University of British Columbia

patents

1 out of 42

La Jolla Pharmaceutical Company

patents

1 out of 4

Seneb Biosciences, Inc.

patents

where one patent can have more than one assignee

Years Active: 1998-2023

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11639348 - Compositions and methods for neuraminidase detection and quantification (2023-05-02),

2. 11608353 - Amylase inhibitor compounds, methods of their use and compositions thereof (2023-03-21),

3. 10583167 - Mammalian glucosidase inhibitors, methods for their use and pharmaceutical compositions thereof (2020-03-10),

4. 10294504 - Mutant endoglycoceramidases with enhanced synthetic activity (2019-05-21),

5. 10023601 - Hydrolysis resistant sialic acid derivatives and methods for their use (2018-07-17),

6. 9949945 - 3' equatorial-fluorine-substituted neuraminidase inhibitor compounds, compositions and methods for the use thereof as anti-virals (2018-04-24),

7. 9834534 - Neuraminidase inhibitor compounds, compositions and methods for the use thereof in anti-viral treatments (2017-12-05),

8. 9637465 - 3' Equatorial-fluorine-substituted neuraminidase inhibitor compounds, compositions and methods for the use thereof as anti-virals (2017-05-02),

9. 9604954 - 2,3-Fluorinated glycosides as neuraminidase inhibitors and their use as anti-virals (2017-03-28),

10. 9382284 - Neuraminidase inhibitor compounds, compositions and methods for the use thereof in anti-viral treatments (2016-07-05),

11. 9221859 - 2,3-fluorinated glycosides as neuraminidase inhibitors and their use as anti-virals (2015-12-29),

12. 9068208 - Mutant endoglycoceramidases with enhanced synthetic activity (2015-06-30),

13. 8907111 - Neuraminidase inhibitor compounds, compositions and methods for the use thereof in anti-viral treatments (2014-12-09),

14. 8815941 - 2,3-fluorinated glycosides as neuraminidase inhibitors and their use as anti-virals (2014-08-26),

15. 8431541 - Alpha-amylase inhibitors: the montbretins and uses thereof (2013-04-30),

Certainly! Here's the article based on the data provided:

Title: Unveiling the Inventive Mind of Stephen G Withers

Introduction:

Stephen G Withers, a prolific inventor hailing from Vancouver, CA, has left a significant mark in the field of innovation with his remarkable contributions. With an impressive portfolio comprising 20 patents, his groundbreaking work continues to inspire many in the realm of scientific discovery.

Latest Patents:

Among his latest patents is the development of compositions and methods for neuraminidase detection and quantification. These compounds, characterized by Formulas A-D, play a crucial role in the accurate assessment of viral neuraminidase levels, aiding in the evaluation of viral strains and vaccine effectiveness. Additionally, Withers has introduced amylase inhibitor compounds, along with methods for their utilization in inhibiting α-amylase, showcasing his versatility in addressing diverse scientific challenges.

Career Highlights:

Withers has enriched his inventive journey through notable tenures at esteemed institutions such as the University of British Columbia and the La Jolla Pharmaceutical Company. These experiences have not only shaped his innovative prowess but have also fostered collaborations that have propelled his research endeavors to new heights.

Collaborations:

Collaborating closely with accomplished peers like Andrew Graham Watts and Jin Hyo Kim, Withers has fostered a culture of shared expertise and collective innovation. Together, they have synergized their talents to pioneer advancements that have the potential to revolutionize the landscape of scientific exploration.

Conclusion:

Stephen G Withers stands as a beacon of ingenuity, with his relentless pursuit of innovation redefining the boundaries of scientific achievement. His unwavering dedication to pushing the frontiers of knowledge underscores his status as a trailblazing inventor, whose legacy continues to inspire and captivate the realm of invention.

This text is generated by artificial intelligence and may not be accurate.